PT Saptausaha Gemilangindah Tbk (SAGE)

Sage Therapeutics Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for Sage Therapeutics stock had an average target of 9.37, with a low estimate of 4.00 and a high estimate of 26.

Price Target: $9.37 (+7.95%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$4.00	$9.37	$9.00	$26
Change	-53.92%	+7.95%	+3.69%	+199.54%

* Price targets were last updated on Jul 8, 2025.

Analyst Ratings

The average analyst rating for Sage Therapeutics stock from 16 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	3	3	3	3	2	1
Hold	15	15	14	14	15	14
Sell	1	1	1	1	1	1
Strong Sell	1	1	1	1	0	0
Total	20	20	19	19	18	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
George Farmer Scotiabank	Scotiabank	Buy → Hold Downgrades $12 → $9.2	Buy → Hold	Downgrades	$12 → $9.2	+5.99%	Jul 8, 2025
Joel Beatty Baird	Baird	Hold Maintains $7 → $9	Hold	Maintains	$7 → $9	+3.69%	Jun 20, 2025
David Amsellem Piper Sandler	Piper Sandler	Buy → Hold Downgrades $9 → $8.5	Buy → Hold	Downgrades	$9 → $8.5	-2.07%	Jun 17, 2025
Joon Lee Truist Securities	Truist Securities	Hold Maintains $8 → $9	Hold	Maintains	$8 → $9	+3.69%	Jun 17, 2025
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $12	Hold	Reiterates	$12	+38.25%	Jun 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

83.97M

Increased by 103.60%

from 41.24M

Revenue Next Year

120.02M

Increased by 42.93%

from 83.97M

EPS This Year

-3.67

from -6.59

EPS Next Year

-2.94

from -3.67

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.11B	6.31M	7.69M	86.46M	41.24M	83.97M	120.02M	158.71M
Revenue Growth	16,123.06%	-99.43%	21.85%	1,024.84%	-52.30%	103.60%	42.93%	32.24%
EPS	11.43	-7.80	-8.98	-9.05	-6.59	-3.67	-2.94	-2.00
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	20	20	15

Financial currency is IDR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	136.4M	198.7M	229.8M
Avg	84.0M	120.0M	158.7M
Low	61.7M	78.4M	116.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	230.7%	136.6%	91.5%
Avg	103.6%	42.9%	32.2%
Low	49.6%	-6.6%	-3.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-3.08	-1.76	-0.74
Avg	-3.67	-2.94	-2.00
Low	-3.90	-3.85	-3.90

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.